SCHIZOPHRENIA BULLETIN

Scope & Guideline

Innovating treatment approaches for schizophrenia.

Introduction

Immerse yourself in the scholarly insights of SCHIZOPHRENIA BULLETIN with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN0586-7614
PublisherOXFORD UNIV PRESS
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1973 to 2024
AbbreviationSCHIZOPHRENIA BULL / Schizophr. Bull.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND

Aims and Scopes

The 'Schizophrenia Bulletin' focuses on advancing the understanding of schizophrenia and related disorders through a multidisciplinary approach. The journal aims to disseminate high-quality research that spans various aspects of schizophrenia, including neurobiological, psychological, and social dimensions.
  1. Neurobiological Mechanisms:
    Research exploring the underlying neurobiological mechanisms of schizophrenia, including genetics, neuroimaging, and molecular biology, to better understand the pathophysiology of the disorder.
  2. Psychological and Cognitive Aspects:
    Studies examining cognitive deficits, emotional regulation, and psychosocial factors that contribute to the experience of schizophrenia, emphasizing the interplay between mental processes and symptoms.
  3. Treatment and Intervention Strategies:
    Investigations into pharmacological and non-pharmacological interventions, including cognitive remediation, psychosocial therapies, and innovative treatment approaches such as digital health interventions.
  4. Epidemiological and Public Health Perspectives:
    Research addressing epidemiology, risk factors, and health disparities related to schizophrenia, focusing on societal impacts and the effectiveness of public health strategies.
  5. Transdiagnostic Approaches:
    Explorations of concepts that span various psychiatric disorders, including the study of psychosis risk and shared mechanisms with other mental health conditions.
The 'Schizophrenia Bulletin' has shown a dynamic shift in focus towards emerging themes that resonate with current clinical and societal needs in the field of schizophrenia research.
  1. Digital Health Interventions:
    A growing number of studies explore the efficacy of digital health technologies, such as teletherapy and mobile health applications, highlighting their potential to improve access to care and patient outcomes.
  2. Transdiagnostic Research:
    An increase in research that examines psychosis across various diagnostic categories, emphasizing shared mechanisms and risk factors, reflecting a move towards understanding mental health in a more integrated manner.
  3. Cognitive Remediation and Functionality:
    There is a notable rise in studies investigating cognitive remediation strategies aimed at improving functional outcomes in individuals with schizophrenia, indicating a shift towards enhancing quality of life.
  4. Social and Environmental Factors:
    Emerging research emphasizes the role of social determinants, such as socioeconomic status and childhood adversity, in the onset and progression of schizophrenia, underscoring the need for a holistic understanding of the disorder.
  5. Machine Learning and AI in Psychiatry:
    The application of machine learning and artificial intelligence to predict treatment responses, identify biomarkers, and enhance diagnostic accuracy is on the rise, indicating a trend towards incorporating advanced technology in psychiatric research.

Declining or Waning

While the journal continues to cover a broad range of topics, certain areas of research appear to be declining in prominence based on recent publications.
  1. Historical Perspectives on Antipsychotic Medications:
    Although historical analyses of antipsychotic medications have been foundational, recent publications indicate a shift towards contemporary research focusing on innovative interventions and current treatment paradigms.
  2. Single-Disease Focus:
    There seems to be a waning emphasis on studies that exclusively examine schizophrenia without considering comorbid conditions or broader psychiatric contexts, reflecting a trend towards more integrated approaches.
  3. Basic Science Studies:
    The volume of purely basic science studies, such as animal models without translational implications, appears to be decreasing, as the journal increasingly prioritizes research with direct clinical relevance.

Similar Journals

PSYCHOLOGICAL MEDICINE

Fostering innovation in psychiatric science.
Publisher: CAMBRIDGE UNIV PRESSISSN: 0033-2917Frequency: 16 issues/year

PSYCHOLOGICAL MEDICINE is a leading journal in the field of psychiatry and psychology, published by Cambridge University Press. With its ISSN 0033-2917 and E-ISSN 1469-8978, this journal has firmly established itself as a premier platform for cutting-edge research since its inception in 1970. It consistently ranks in the top quartile for both Applied Psychology and Psychiatry and Mental Health, reflecting its exceptional impact in the field, with a 2023 Scopus ranking of #36 out of 567 in Psychiatry and Mental Health, and #21 out of 249 in Applied Psychology. The journal aims to publish comprehensive studies that explore the interplay between psychological phenomena and medical health, contributing vital insights that advance both theoretical understanding and clinical practice. Although it is not an Open Access journal, PSYCHOLOGICAL MEDICINE remains a vital resource for researchers, professionals, and students committed to the scientific investigation of mental health issues.

Brazilian Journal of Psychiatry

Transforming psychiatric practices through open access knowledge.
Publisher: ASSOC BRASILEIRA PSIQUIATRIAISSN: 1516-4446Frequency: 4 issues/year

The Brazilian Journal of Psychiatry is a prominent peer-reviewed journal dedicated to advancing the field of psychiatry and mental health, published by the Associação Brasileira de Psiquiatria. With an impressive Q2 ranking in the Psychiatry and Mental Health category for 2023 and a Scopus rank of #130 out of 567, this journal serves as a vital resource for researchers, clinicians, and students alike. Since its transition to Open Access in 1999, it has aimed to disseminate high-quality research, innovative practices, and critical insights relevant to mental health in Brazil and beyond. The journal's focus spans various topics in psychiatry, aiming to bridge the gap between research and clinical application, making it essential reading for professionals and academicians committed to improving mental health outcomes. With a commitment to fostering scholarly discourse, the Brazilian Journal of Psychiatry not only enriches the academic landscape but also enhances the practice of psychiatry through its widespread accessibility and dedication to excellence in research.

Spanish Journal of Psychiatry and Mental Health

Transforming mental health understanding with every publication.
Publisher: ELSEVIER ESPANA SLUISSN: 2950-2861Frequency: 4 issues/year

Welcome to the Spanish Journal of Psychiatry and Mental Health, a leading platform for innovative research and discourse in the fields of psychiatry and mental health. Published by ELSEVIER ESPANA SLU, this peer-reviewed journal serves as a critical resource for clinicians, researchers, and students dedicated to advancing understanding and treatment of mental health disorders. With a commendable ranking of #54 out of 567 in the Psychiatry and Mental Health category according to Scopus, it proudly positions itself in the 90th percentile, reinforcing its significance within the academic community. As an open-access journal, it aims to disseminate high-quality research to a global audience, promoting collaboration and knowledge sharing among mental health professionals. The journal's dynamic publication schedule, covering Converged Years from 2023 to 2024, ensures that it remains at the forefront of mental health scholarship. We invite you to explore the latest findings, engage with thought-provoking articles, and contribute to the ongoing dialogue in this vital discipline.

BRITISH JOURNAL OF PSYCHIATRY

Charting New Territories in Psychiatric Studies
Publisher: CAMBRIDGE UNIV PRESSISSN: 0007-1250Frequency: 12 issues/year

British Journal of Psychiatry, published by Cambridge University Press, stands as a pivotal resource in the realm of mental health and psychiatry. With an impressive impact reflected in its Q1 classifications in both Medicine (miscellaneous) and Psychiatry and Mental Health, this esteemed journal ranks 23rd out of 567 in its field according to Scopus, achieving an exceptional 96th percentile. Since its inception in 1963, the journal has continued to push the boundaries of research and discourse, serving as a platform for groundbreaking studies that enhance our understanding of psychiatric conditions and promote effective therapeutic strategies. Though it does not operate with an open-access model, the British Journal of Psychiatry remains an essential publication for researchers, clinicians, and students alike, offering in-depth insights and innovative findings that are crucial for navigating the complexities of mental health.

NPJ Schizophrenia

Advancing psychiatric research for a deeper understanding of schizophrenia.
Publisher: NATURE PORTFOLIOISSN: Frequency: 1 issue/year

NPJ Schizophrenia is a premier open-access journal published by NATURE PORTFOLIO, dedicated to advancing the field of psychiatric research with a focus on schizophrenia and related mental health disorders. Since its inception in 2015, the journal has established itself as a leading platform for disseminating high-quality research, reflected in its impressive 2023 impact metrics: Q1 rankings in Biological Psychiatry, Clinical Psychology, and Psychiatry and Mental Health. With its global reach and rigorous peer-review process, NPJ Schizophrenia fosters collaboration among researchers, clinicians, and policymakers, enhancing understanding and treatment of this complex condition. The journal is available to a worldwide audience, promoting accessibility to vital information that shapes future research and clinical practices. Engaging with NPJ Schizophrenia means contributing to a pivotal conversation in the mental health field, making it an essential resource for those dedicated to improving patient outcomes.

NEUROPSYCHOBIOLOGY

Exploring the Mind: Where Neuroscience Meets Psychology
Publisher: KARGERISSN: 0302-282XFrequency: 6 issues/year

NEUROPSYCHOBIOLOGY, published by KARGER, is a leading academic journal that has been at the forefront of exploring the intricate relationships between neuroscience and psychological processes since its inception in 1975. With both an ISSN of 0302-282X and an E-ISSN of 1423-0224, the journal is renowned for its rigorous peer-reviewed articles and significant contributions to the fields of Biological Psychiatry, Neuropsychology, and Physiological Psychology. Its impact is reflected in its esteemed Scopus rankings, standing out in the 92nd and 81st percentiles in their respective categories. With a commitment to advancing understanding in mental health and neurological science, NEUROPSYCHOBIOLOGY is classified in the Q3 and Q1 quartiles, making it a vital resource for researchers, clinicians, and students alike. Based in Switzerland, the journal embraces a holistic approach to psychological research, bridging gaps between theoretical frameworks and practical applications, thus promoting impactful advancements in the understanding of the human mind.
Explore the latest findings and theories with NEUROPSYCHOBIOLOGY, where your work can contribute to the evolving landscape of neuropsychological studies.

Psychogeriatrics

Elevating the discourse on aging and mental health.
Publisher: WILEYISSN: 1346-3500Frequency: 4 issues/year

Psychogeriatrics is a leading peer-reviewed journal published by WILEY, dedicated to advancing the understanding of mental health and geriatric psychiatry. With an ISSN of 1346-3500 and an E-ISSN of 1479-8301, this journal has been integral to the field since its inception in 2005 and continues to publish cutting-edge research until 2024. Recognized for its impact, Psychogeriatrics holds a commendable Q2 quartile ranking in Geriatrics and Gerontology, Gerontology, and Psychiatry and Mental Health as of 2023. The journal's Scopus rankings reflect its significant contribution to Nursing Gerontology, Medicine Psychiatry and Mental Health, and Medicine Geriatrics and Gerontology. Although it operates with no open access options, Psychogeriatrics remains a vital resource for researchers, professionals, and students who are exploring the complexities of mental health in older populations. The journal not only disseminates innovative research but also tackles pressing issues related to the psychological well-being of the elderly, making it essential reading for anyone focused on improving geriatric mental health care.

Neuropsychopharmacology Reports

Pioneering discoveries in the field of neuropsychopharmacology.
Publisher: WILEYISSN: Frequency: 4 issues/year

Neuropsychopharmacology Reports is a leading open-access journal published by WILEY, dedicated to advancing the fields of clinical psychology, pharmacology, psychiatry, and mental health. Established in 2018, the journal aims to disseminate high-quality research findings, critical reviews, and innovative methodologies that elucidate the complexities of neuropsychopharmacology in enhancing mental health outcomes. With an impressive impact indicated by its Q2 rankings in several categories including Clinical Psychology and Pharmacology (medical) as of 2023, Neuropsychopharmacology Reports stands out as a vital resource for researchers, professionals, and students keen on exploring the interplay between pharmacological interventions and psychological well-being. The journal’s open-access nature ensures that critical advancements in this rapidly evolving field are readily available to a global audience, fostering collaboration and discourse among scholars and practitioners alike. Building on its indexed status with Scopus, the journal is positioned as a noteworthy contributor to ongoing discussions and developments in psychiatry and medical pharmacology.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Bridging gaps in geriatric mental health knowledge.
Publisher: WILEYISSN: 0885-6230Frequency: 12 issues/year

International Journal of Geriatric Psychiatry, published by Wiley, stands as a premier journal dedicated to advancing the field of mental health in older adults. With an impressive impact factor reflective of its Q1 categorization in both Geriatrics and Gerontology, as well as Psychiatry and Mental Health, this journal addresses the critical intersection of aging and mental health, providing a platform for impactful research from 1986 through 2024. Researchers and professionals will find the journal invaluable, as it offers comprehensive insights into a range of subjects pertinent to geriatric mental health, with its ranking in Scopus highlighting its academic rigor and relevance (Rank #147/567 in Psychiatry and Mental Health; Rank #37/116 in Geriatrics and Gerontology). Though it operates on a traditional subscription model, the journal's significant contributions to the understanding of psychiatric disorders in the elderly make it a key resource for anyone involved in geriatric care and research.

CURRENT OPINION IN PSYCHIATRY

Fostering Knowledge for Mental Health Professionals
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0951-7367Frequency: 6 issues/year

Current Opinion in Psychiatry is a premier journal published by Lippincott Williams & Wilkins, dedicated to the dynamic and evolving field of psychiatry and mental health. With a commendable impact factor and ranking 30th out of 567 in the Scopus database, this journal occupies a Q1 quartile position, reflecting its significance and influence within the academic community. Since its inception in 1988, Current Opinion in Psychiatry has aimed to provide critical reviews, leading research, and expert opinions that shape clinical practice and decision-making in psychiatry. While the journal is not open access, it continues to serve as an essential resource for researchers, clinicians, and students seeking insights into contemporary psychiatric challenges and advancements. With its ongoing commitment to high-quality content, the journal remains a vital platform for knowledge dissemination and dialog in the field.